Rabies - You don't know what you know

Human rabies cases are fortunately rare in the US. Access to pre- and post-exposure prophylaxis, and domestic animal vaccination programs, drive this public health success. This comes at a financial and human resources cost. Dr. Kyle Weant, clinical assistant professor and an emergency medical clinical pharmacy specialist at the University of South Carolina College of Pharmacy and Dr. Philippe Mentler, senior consulting director, join host Gretchen Brummel to discuss the use of rabies immune globulin and rabies vaccine in patients who have been exposed and provide treatment pearls for frontline pharmacy practioners.

 

Guest speakers:

Kyle Weant, PharmD, BCPS, BCCCP, FCCP

Clinical Assistant Professor and an Emergency Medical Clinical Pharmacy Specialist

University of South Carolina College of Pharmacy

 

Philippe Mentler, PharmD, BCPS

Senior Consulting Director

Vizient

 

Host: 

Gretchen Brummel, PharmD, BCPS

 

Show Notes: 

[00:54-01:17] Kyle’s background information 

[01:18-03:31] Rabies as a disease

[03:32-05:13] Public Awareness

[05:14-07:06] Options right now for post-exposure prophylaxis

[07:07-10:01] Thoughts on dose rounding

[10:02-10:13] Is rabies immunoglobulin considered an essential medication that everyone should stock in their hospital pharmacy

[10:14-11:30] Who should be administering these drugs? And who's ensuring follow up of these patients?

[11:31-14:31] Potential pitfalls in patient management

[14:32-18:12] What should our frontline pharmacy staff know about post-exposure prophylaxis

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed